Variant report
Variant | nsv963240 |
---|---|
Chromosome Location | chr2:64573534-64575614 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr2:64575443-64575987 | H1-neurons | neurons: | n/a | n/a |
2 | POLR2A | chr2:64575413-64576137 | H1-neurons | neurons: | n/a | n/a |
3 | RAD21 | chr2:64574635-64574798 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000236148 | TF binding region |
ENSG00000238201 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35125530 | chr2:64573555-64573556 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs139320276 | chr2:64573583-64573584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs4459720 | chr2:64573642-64573643 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs192615159 | chr2:64573681-64573682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564032014 | chr2:64573723-64573724 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7600180 | chr2:64573732-64573733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549526842 | chr2:64573798-64573799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561640509 | chr2:64573835-64573836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144316681 | chr2:64573851-64573852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548885197 | chr2:64573855-64573856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs201010284 | chr2:64573917-64573918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571375967 | chr2:64573918-64573919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567109366 | chr2:64573942-64573943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534325469 | chr2:64573977-64573978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553832465 | chr2:64573998-64573999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs117680100 | chr2:64574051-64574052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111247707 | chr2:64574083-64574084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13008221 | chr2:64574128-64574129 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs78428545 | chr2:64574136-64574137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538299358 | chr2:64574183-64574184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1365477 | chr2:64574188-64574189 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs574468291 | chr2:64574189-64574190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112219931 | chr2:64574224-64574225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183358206 | chr2:64574256-64574257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572259401 | chr2:64574271-64574272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187568910 | chr2:64574294-64574295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192112272 | chr2:64574343-64574344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184327569 | chr2:64574355-64574356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564275330 | chr2:64574439-64574440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576079646 | chr2:64574486-64574487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576467214 | chr2:64574515-64574516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556940857 | chr2:64574606-64574607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs370901713 | chr2:64574619-64574620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543522161 | chr2:64574655-64574656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561701589 | chr2:64574669-64574670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs2059631 | chr2:64574682-64574683 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs545650604 | chr2:64574689-64574690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560770206 | chr2:64574707-64574708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527945319 | chr2:64574710-64574711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs61739224 | chr2:64574717-64574718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141226871 | chr2:64574722-64574723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192886558 | chr2:64574734-64574735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549845712 | chr2:64574735-64574736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs61743098 | chr2:64574749-64574750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535461628 | chr2:64574750-64574751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553712387 | chr2:64574751-64574752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184475213 | chr2:64574788-64574789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145510863 | chr2:64574817-64574818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189555767 | chr2:64574844-64574845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576172038 | chr2:64574860-64574861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Leukoplakia | 24403051 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:64568400-64575800 | Weak transcription | Fetal Muscle Leg | muscle |
2 | chr2:64572600-64581800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr2:64573200-64573800 | Enhancers | A549 | lung |
4 | chr2:64573800-64576000 | Weak transcription | A549 | lung |
5 | chr2:64575000-64576400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr2:64575200-64576600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr2:64575400-64575600 | Flanking Active TSS | NHDF-Ad | bronchial |
8 | chr2:64575400-64576000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr2:64575400-64576000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
10 | chr2:64575400-64576200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr2:64575400-64576200 | Enhancers | NH-A | brain |
12 | chr2:64575400-64576400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
13 | chr2:64575400-64576600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr2:64575400-64576800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
15 | chr2:64575400-64576800 | Enhancers | NHLF | lung |
16 | chr2:64575600-64576200 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
17 | chr2:64575600-64576400 | Enhancers | Muscle Satellite Cultured Cells | -- |
18 | chr2:64575600-64576600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
19 | chr2:64575600-64576600 | Enhancers | NHDF-Ad | bronchial |
20 | chr2:64575600-64576600 | Enhancers | NHEK | skin |